Prolactin Deficiency Treatment & Management

1. Cosman F, Post KD, Holub DA, et al. Lymphocytic hypophysitis. Report of 3 new cases and review of the literature. Medicine (Baltimore). 1989 Jul. 68(4):240-56. [QxMD MEDLINE Link].

2. Thodou E, Asa SL, Kontogeorgos G, et al. Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab. 1995 Aug. 80(8):2302-11. [QxMD MEDLINE Link]. [Full Text].

3. Toledano Y, Lubetsky A, Shimon I. Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis. J Endocrinol Invest. 2007 Apr. 30(4):268-73. [QxMD MEDLINE Link].

4. Gounden V, Anastasopoulou C, Jialal I. Hypopituitarism. StatPearls. 2023 Jan. [QxMD MEDLINE Link]. [Full Text].

5. Prencipe N, Marinelli L, Varaldo E, et al. Isolated anterior pituitary dysfunction in adulthood. Front Endocrinol (Lausanne). 2023. 14:1100007. [QxMD MEDLINE Link]. [Full Text].

6. Zargar AH, Masoodi SR, Laway BA, et al. Familial puerperal alactogenesis: possibility of a genetically transmitted isolated prolactin deficiency. Br J Obstet Gynaecol. 1997 May. 104(5):629-31. [QxMD MEDLINE Link].

7. Falk RJ. Isolated prolactin deficiency: a case report. Fertil Steril. 1992 Nov. 58(5):1060-2. [QxMD MEDLINE Link].

8. Kauppila A, Chatelain P, Kirkinen P, et al. Isolated prolactin deficiency in a woman with puerperal alactogenesis. J Clin Endocrinol Metab. 1987 Feb. 64(2):309-12. [QxMD MEDLINE Link].

9. Swaminathan G, Varghese B, Thangavel C, et al. Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J Endocrinol. 2008 Feb. 196(2):R1-7. [QxMD MEDLINE Link].

10. Oseko F, Nakano A, Morikawa K, et al. Effects of chronic bromocriptine-induced hypoprolactinemia on plasma testosterone responses to human chorionic gonadotropin stimulation in normal men. Fertil Steril. 1991 Feb. 55(2):355-7. [QxMD MEDLINE Link].

11. Russell DH, Kibler R, Matrisian L, et al. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol. 1985 May. 134(5):3027-31. [QxMD MEDLINE Link].

12. Bernton EW, Meltzer MS, Holaday JW. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science. 1988 Jan 22. 239(4838):401-4. [QxMD MEDLINE Link].

13. Carrier M, Wild J, Pelletier LC, et al. Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation. Ann Thorac Surg. 1990 Jan. 49(1):129-32. [QxMD MEDLINE Link].

14. Palestine AG, Nussenblatt RB, Gelato M. Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine. Transplant Proc. 1988 Jun. 20(3 Suppl 4):131-5. [QxMD MEDLINE Link].

15. Lucas A, Baker BA, Cole TJ. Plasma prolactin and clinical outcome in preterm infants. Arch Dis Child. 1990 Sep. 65(9):977-83. [QxMD MEDLINE Link]. [Full Text].

16. Bonomo IT, Lisboa PC, Pereira AR, et al. Prolactin inhibition in dams during lactation programs for overweight and leptin resistance in adult offspring. J Endocrinol. 2007 Feb. 192(2):339-44. [QxMD MEDLINE Link].

17. Laway BA, Mir SA, Gojwari T, Shah TR, Zargar AH. Selective preservation of anterior pituitary functions in patients with Sheehan's syndrome. Indian J Endocrinol Metab. 2011 Sep. 15 Suppl 3:S238-41. [QxMD MEDLINE Link]. [Full Text].

18. Shivaprasad C. Sheehan's syndrome: Newer advances. Indian J Endocrinol Metab. 2011 Sep. 15 Suppl 3:S203-7. [QxMD MEDLINE Link]. [Full Text].

19. Leng L, Zhang Y. Effects of an estrogen receptor antagonist on proliferation, prolactin secretion and growth factor expression in the MMQ pituitary prolactinoma cell line. J Clin Neurosci. 2011 Oct 18. [QxMD MEDLINE Link].

20. Krysiak R, Kowalcze K, Okopień B. Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study. Cardiology. 2022. 147 (5-6):497-506. [QxMD MEDLINE Link]. [Full Text].

21. Fofanova O, Takamura N, Kinoshita E, et al. Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab. 1998 Jul. 83(7):2601-4. [QxMD MEDLINE Link]. [Full Text].

22. Rosenbloom AL, Almonte AS, Brown MR, et al. Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab. 1999 Jan. 84(1):50-7. [QxMD MEDLINE Link]. [Full Text].

23. Yang H, Dixit VD, Patel K, et al. Reduction in hypophyseal growth hormone and prolactin expression due to deficiency in ghrelin receptor signaling is associated with Pit-1 suppression: relevance to the immune system. Brain Behav Immun. 2008 Jun 17. [QxMD MEDLINE Link].

24. Samuels MH, Henry P, Kleinschmidt-Demasters B, et al. Pulsatile prolactin secretion in hyperprolactinemia due to presumed pituitary stalk interruption. J Clin Endocrinol Metab. 1991 Dec. 73(6):1289-93. [QxMD MEDLINE Link].

25. Diaz S, Seron-Ferre M, Cardenas H, et al. Circadian variation of basal plasma prolactin, prolactin response to suckling, and length of amenorrhea in nursing women. J Clin Endocrinol Metab. 1989 May. 68(5):946-55. [QxMD MEDLINE Link].

26. Stawerska R, Lewinski A, Smyczynska J, et al. Circadian pattern of prolactin secretion in children with growth hormone deficiency and congenital organic lesions in the hypothalamic-pituitary region. Neuro Endocrinol Lett. 2007 Dec. 28(6):765-74. [QxMD MEDLINE Link].

27. Ehrenkranz RA, Ackerman BA. Metoclopramide effect on faltering milk production by mothers of premature infants. Pediatrics. 1986 Oct. 78(4):614-20. [QxMD MEDLINE Link].

28. Gupta AP, Gupta PK. Metoclopramide as a lactogogue. Clin Pediatr (Phila). 1985 May. 24(5):269-72. [QxMD MEDLINE Link].

29. Kauppila A, Anunti P, Kivinen S, et al. Metoclopramide and breast feeding: efficacy and anterior pituitary responses of the mother and the child. Eur J Obstet Gynecol Reprod Biol. 1985 Jan. 19(1):19-22. [QxMD MEDLINE Link].

30. Kauppila A, Kivinen S, Ylikorkala O. A dose response relation between improved lactation and metoclopramide. Lancet. 1981 May 30. 1(8231):1175-7. [QxMD MEDLINE Link].

31. Kauppila A, Kivinen S, Ylikorkala O. Metoclopramide increases prolactin release and milk secretion in puerperium without stimulating the secretion of thyrotropin and thyroid hormones. J Clin Endocrinol Metab. 1981 Mar. 52(3):436-9. [QxMD MEDLINE Link].

32. Sousa PL. Letter: Metoclopramide and breast-feeding. Br Med J. 1975 Mar 1. 1(5956):512. [QxMD MEDLINE Link]. [Full Text].

33. Andersen AN, Lund-Andersen C, Larsen JF, et al. Suppressed prolactin but normal neurophysin levels in cigarette smoking breast-feeding women. Clin Endocrinol (Oxf). 1982 Oct. 17(4):363-8. [QxMD MEDLINE Link].

Charles T Benson, MD, PhD Medical Fellow, Eli Lilly and Company, UK

Disclosure: Received salary from Eli Lilly & Co for employment.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Yoram Shenker, MD Chief of Endocrinology Section, Veterans Affairs Medical Center of Madison; Interim Chief, Associate Professor, Department of Internal Medicine, Section of Endocrinology, Diabetes and Metabolism, University of Wisconsin at Madison

Yoram Shenker, MD is a member of the following medical societies: American Heart Association, Central Society for Clinical and Translational Research, Endocrine Society

Disclosure: Nothing to disclose.

George T Griffing, MD Professor Emeritus of Medicine, St Louis University School of Medicine

George T Griffing, MD is a member of the following medical societies: American Association for Physician Leadership, American Association for the Advancement of Science, American College of Medical Practice Executives, American College of Physicians, American Diabetes Association, American Federation for Medical Research, American Heart Association, Central Society for Clinical and Translational Research, Endocrine Society, International Society for Clinical Densitometry, Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

Frederick H Ziel, MD Associate Professor of Medicine, University of California, Los Angeles, David Geffen School of Medicine; Physician-In-Charge, Endocrinology/Diabetes Center, Director of Medical Education, Kaiser Permanente Woodland Hills; Chair of Endocrinology, Co-Chair of Diabetes Complete Care Program, Southern California Permanente Medical Group

Frederick H Ziel, MD is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Endocrinology, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Diabetes Association, American Federation for Medical Research, American Medical Association, American Society for Bone and Mineral Research, California Medical Association, Endocrine Society, International Society for Clinical Densitometry

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article